InsidersTradesSigma
Follow the WaferGen Bio-systems, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 5 January 2016 (Attribution). Among the most active insiders: Hautamaki R Dean. The full history is accessible without an account.
Analysts rate WaferGen Bio-systems, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
WaferGen Bio-systems, Inc. is a biotechnology company focused on developing solutions for genomic research. It specializes in innovative technologies for DNA and RNA analysis.